Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Military Medical Research|September 30, 2025
Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX studyLe-Qing Cao, Wen-Xuan Huo, Er-Lie Jiang, et al.
Cancer|March 23, 2023
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort studyYing-Ying Ma, Ze-Liang Wei, Ya-Jing Xu, et al.
Transplantation and Cellular Therapy|November 19, 2022
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Dao-Pei Lu, De-Pei Wu, et al.
Bone Marrow Transplantation|September 25, 2024
Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Pei-Hua Lu, De-Pei Wu, et al.
Clinical Transplantation|October 26, 2025
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant RegistryXin Zhao, Ming Zhou, Bao-Dong Ye, et al.
Cancer Letters|February 2, 2026
Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort studyPeng Zhao, Zhi-Xue Li, Er-Lie Jiang, et al.
Cancer Letters|March 29, 2025
Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: A CBMTR Registry-based propensity score matching analysis over the last decadeZheng-Li Xu, Yu-Ping Zhang, Bao-Dong Ye, et al.
American Journal of Hematology|January 22, 2022
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysisXiao-Dong Mo, Shen-Da Hong, Yan-Li Zhao, et al.
Pageof 6